U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H3N2O4.Fe
Molecular Weight 366.022
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS OROTATE

SMILES

[Fe++].[O-]C(=O)C1=CC(=O)NC(=O)N1.[O-]C(=O)C2=CC(=O)NC(=O)N2

InChI

InChIKey=QOOMRZNLVISVGR-UHFFFAOYSA-L
InChI=1S/2C5H4N2O4.Fe/c2*8-3-1-2(4(9)10)6-5(11)7-3;/h2*1H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2

HIDE SMILES / InChI

Description

There is no information about biological o medical application of ferrous orotate. But is known, that this substance may be used for nutritional purposes to food supplements.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Patents

Patents

CN1508131A
1

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
FERROUS OROTATE
Common Name English
FERROUS OROTATE [JAN]
Common Name English
4-PYRIMIDINECARBOXYLIC ACID, 1,2,3,6-TETRAHYDRO-2,6-DIOXO-, IRON(2+) SALT (2:1)
Systematic Name English
Code System Code Type Description
FDA UNII
05G695I850
Created by admin on Sat Dec 16 08:01:57 GMT 2023 , Edited by admin on Sat Dec 16 08:01:57 GMT 2023
PRIMARY
CAS
94333-36-5
Created by admin on Sat Dec 16 08:01:57 GMT 2023 , Edited by admin on Sat Dec 16 08:01:57 GMT 2023
PRIMARY
ECHA (EC/EINECS)
305-013-8
Created by admin on Sat Dec 16 08:01:57 GMT 2023 , Edited by admin on Sat Dec 16 08:01:57 GMT 2023
PRIMARY
PUBCHEM
55317
Created by admin on Sat Dec 16 08:01:57 GMT 2023 , Edited by admin on Sat Dec 16 08:01:57 GMT 2023
PRIMARY
SUBSTANCE RECORD
Structure of FERROUS OROTATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966